Forecasting The Future: 11 Analyst Projections For AbbVie
Portfolio Pulse from Benzinga Insights
In the past three months, 11 analysts have provided ratings for AbbVie (NYSE:ABBV), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 6.68% to $209.73. Analysts have raised their price targets, reflecting positive sentiment towards AbbVie's market position and financial performance.
October 25, 2024 | 9:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AbbVie has received predominantly bullish analyst ratings, with an increase in the average 12-month price target to $209.73, indicating positive sentiment. Analysts have raised their price targets, reflecting confidence in AbbVie's financial performance and market position.
The article highlights a positive shift in analyst sentiment towards AbbVie, with several analysts raising their price targets. This suggests a favorable outlook on AbbVie's financial performance and market position, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100